PARAMETRIC PORTFOLIO ASSOCIATES LLC - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 114 filers reported holding ALBIREO PHARMA INC in Q3 2020. The put-call ratio across all filers is 7.29 and the average weighting 0.2%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q1 2022$1,898,000
+78.6%
63,616
+39.4%
0.00%0.0%
Q4 2021$1,063,000
-49.1%
45,647
-31.8%
0.00%0.0%
Q3 2021$2,089,000
-1.3%
66,968
+11.3%
0.00%0.0%
Q2 2021$2,116,000
+19.4%
60,156
+19.6%
0.00%0.0%
Q1 2021$1,772,000
+35.4%
50,277
+44.0%
0.00%0.0%
Q4 2020$1,309,000
-11.5%
34,909
-21.2%
0.00%0.0%
Q3 2020$1,479,000
+81.9%
44,317
+44.4%
0.00%0.0%
Q2 2020$813,000
+80.7%
30,691
+11.6%
0.00%
Q1 2020$450,000
-37.8%
27,508
-3.4%
0.00%
-100.0%
Q4 2019$724,000
+83.8%
28,464
+44.5%
0.00%
Q3 2019$394,000
-40.9%
19,693
-4.8%
0.00%
-100.0%
Q2 2019$667,000
-10.7%
20,688
-10.8%
0.00%0.0%
Q1 2019$747,000
+25.8%
23,193
-4.2%
0.00%0.0%
Q4 2018$594,000
-40.8%
24,216
-20.4%
0.00%0.0%
Q3 2018$1,003,000
+35.5%
30,439
+46.1%
0.00%0.0%
Q2 2018$740,000
+38.8%
20,840
+27.4%
0.00%0.0%
Q1 2018$533,00016,3550.00%
Other shareholders
ALBIREO PHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Prosight Management, LP 514,082$11,973,0007.17%
Privium Fund Management B.V. 379,117$8,959,0001.78%
Birchview Capital, LP 113,000$2,632,0001.70%
Sio Capital Management, LLC 213,913$4,982,0001.50%
Perceptive Advisors 4,720,278$109,936,0000.85%
Chicago Capital, LLC 849,239$19,779,0000.74%
APOGEM CAPITAL LLC 38,601$899,0000.59%
Samsara BioCapital, LLC 100,000$2,329,0000.45%
Artal Group S.A. 600,000$13,974,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 458,011$10,667,0000.38%
View complete list of ALBIREO PHARMA INC shareholders